Literature DB >> 10599858

Over-expression of P-glycoprotein in malformations of cortical development.

S M Sisodiya1, J Heffernan, M V Squier.   

Abstract

Drug resistance in epilepsy due to malformations of cortical development (MCD) is unexplained. P-glycoprotein is a mediator of drug resistance, and we propose that MCD lesions over-express P-glycoprotein. Because P-glycoprotein expression may be induced by some antiepileptic drugs (AEDs), we studied brain samples from MCD cases before the onset of seizures or treatment with AEDs. Sixteen MCD cases and 16 age-matched controls were examined using immunohistochemistry. Glial labelling, representing over-expression, was seen in 10 of 16 MCD samples and in two of 16 control samples (p = 0.003). Semiquantitative assessment showed many immunoreactive glia in five of 16 MCD and one of 16 controls. We conclude that there is constitutive over-expression of P-glycoprotein in many MCD.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10599858     DOI: 10.1097/00001756-199911080-00032

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  15 in total

Review 1.  Functional expression and localization of P-glycoprotein in the central nervous system: relevance to the pathogenesis and treatment of neurological disorders.

Authors:  Gloria Lee; Reina Bendayan
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

Review 2.  Genetics of drug resistance in epilepsy.

Authors:  Sanjay M Sisodiya
Journal:  Curr Neurol Neurosci Rep       Date:  2005-07       Impact factor: 5.081

3.  Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein.

Authors:  Jun-Sheng Wang; Hao-Jie Zhu; John S Markowitz; Jennifer L Donovan; C Lindsay DeVane
Journal:  Psychopharmacology (Berl)       Date:  2006-06-30       Impact factor: 4.530

Review 4.  Blood-brain barrier active efflux transporters: ATP-binding cassette gene family.

Authors:  Wolfgang Löscher; Heidrun Potschka
Journal:  NeuroRx       Date:  2005-01

Review 5.  Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders.

Authors:  Hisham Qosa; David S Miller; Piera Pasinelli; Davide Trotti
Journal:  Brain Res       Date:  2015-07-15       Impact factor: 3.252

6.  Induction of P-glycoprotein in lymphocytes by carbamazepine and rifampicin: the role of nuclear hormone response elements.

Authors:  Andrew Owen; Chris Goldring; Paul Morgan; B Kevin Park; Munir Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2006-08       Impact factor: 4.335

7.  Pathophysiologic characteristics of balloon cells in cortical dysplasia.

Authors:  Hyun-Sik Oh; Min-Cheol Lee; Hyung-Seok Kim; Ji-Shin Lee; Jae-Hyuk Lee; Myeong-Kyu Kim; Young-Jong Woo; Jae-Hyoo Kim; Hyoung-Ihl Kim; Seung-Up Kim
Journal:  Childs Nerv Syst       Date:  2007-09-26       Impact factor: 1.475

Review 8.  Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options.

Authors:  Wolfgang Löscher; Heidrun Potschka; Sanjay M Sisodiya; Annamaria Vezzani
Journal:  Pharmacol Rev       Date:  2020-07       Impact factor: 25.468

9.  (R)-[11C]verapamil PET studies to assess changes in P-glycoprotein expression and functionality in rat blood-brain barrier after exposure to kainate-induced status epilepticus.

Authors:  Stina Syvänen; Gert Luurtsema; Carla F M Molthoff; Albert D Windhorst; Marc C Huisman; Adriaan A Lammertsma; Rob A Voskuyl; Elizabeth C de Lange
Journal:  BMC Med Imaging       Date:  2011-01-03       Impact factor: 1.930

10.  Limbic seizures induce P-glycoprotein in rodent brain: functional implications for pharmacoresistance.

Authors:  Massimo Rizzi; Silvio Caccia; Giovanna Guiso; Cristina Richichi; Jan A Gorter; Eleonora Aronica; Marisa Aliprandi; Renzo Bagnati; Roberto Fanelli; Maurizio D'Incalci; Rosario Samanin; Annamaria Vezzani
Journal:  J Neurosci       Date:  2002-07-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.